No Data
No Data
Branding Technology: Presentation of financial results for the 3rd quarter of the fiscal year ending March 31, 2025
Branding Technology: Summary of Financial Results for the 3rd Quarter Ending March 31, 2025 [Japanese GAAP] (Consolidated)
Nissan, Honda, Tokyu, Seibu HD (13th) (7014-9994)
The above Calendar is merely a plan and is subject to change due to the company's circumstances. --------------------------------------- February 13 (Thursday) <7014> Namura Zō, <7021> Nichitsus, <7030> Supurikkusu, <7037> Tenno, <7038> Frontier M, <7043> Alu, <7044> Piara, <7047> Port, <7061> Japan Host.
Stocks that moved the previous day part 1 Branding, Makino Milling Machine, Weather News, ETC.
Stock Name <Code> 30-day close ⇒ Compared to the previous day, Polaris HD <3010> 184 +1225 has revised its financial estimates for the fiscal year ending March 2025 upwards. Nagao <6239> 1202 +104 has secured a large order from Screen Internal. Hello's <2742> 4625 +425 reported a positive response to its two-digit profit increase for the third quarter. Palemo HD <2778> 123 -10 has seen a 50.9% decrease in operating profit for the cumulative third quarter. Branding <7067> 1638 +300 Japan Asia Investment <
Afternoon session [Active stocks and traded stocks]
*Polaris HD <3010> 184 +1225 revised financial estimates for the fiscal year ending March. *Nagaoka <6239> 1202 +104 won a large order from Screen Internal. *Hello's <2742> 4625 +425 positive reaction to double-digit increase in third-quarter earnings. *Palemo HD <2778> 123 -10 operating profit down 50.9% for cumulative third quarter. *Branding <7067> 1638 +300 capital and business partnership with Japan Asia Investment <8518>.
Emerging Markets stocks digest: DWTI surged, Headwater briefly hit the daily limit up.
<4576> DWTI 201 +38 surged sharply. It announced that it received notification from Kowa, the licensee, that the glaucoma and ocular hypertension treatment "Graa Alpha Combination Eye Drops (domestic product name)" has been approved in Thailand for the Rho kinase inhibitor Ripasudil hydrochloride hydrate it developed, which is viewed favorably. The product has been on the domestic market since December 2022 through Kowa, and discussions were held regarding overseas sales. This is the first time the product has obtained approval overseas, and Kowa will continue to.